Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project (Q37568787)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on August 2009

Language	Label	Description	Also known as
English	Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project	scientific article published on August 2009

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

1 reference

Europe PubMed Central

Monoclonal antibody-associated progressive multifocal leucoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: a Review from the Research on Adverse Drug Events and Reports (RADAR) Project (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

author name string

Kenneth R Carson

1

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Daniele Focosi

2

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Eugene O Major

3

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Mario Petrini

4

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Elizabeth A Richey

5

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Dennis P West

6

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Charles L Bennett

7

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

publication date

1 August 2009

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

816-824

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

Polyoma-like virions in a human demyelinating disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cerebral demyelination associated with disorders of the reticuloendothelial system

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy in the United States, 1979-1994: increased mortality associated with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

New insights into progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

PML-IRIS in patients with HIV infection: clinical manifestations and treatment with steroids

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy in transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of polyomaviruses in human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

AIDS- and non-AIDS-related PML association with distinct p53 polymorphism

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalitis (PML) in three patients treated with standard-dose fludarabine (FAMP)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of DNA Sequences of BK Virus and JC Virus in Normal Human Tissues and in Diseased Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of JC virus DNA and proteins in the bone marrow of HIV-positive and HIV-negative patients: implications for viral latency and neurotropic transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Detection of JC virus DNA fragments but not proteins in normal brain tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diagnostic value of detecting JC virus DNA in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Regeneration of B cell subsets after transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Response to B-cell depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy in a patient with common variable immunodeficiency and abnormal CD8+ T-cell subset distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy in a patient with X-linked agammaglobulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy in patients with rheumatic diseases: are patients with systemic lupus erythematosus at particular risk?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Increased numbers of circulating hematopoietic stem/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Progressive multifocal leukoencephalopathy in a patient treated with natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

JC virus viremia in interferon-beta -treated and untreated Italian multiple sclerosis patients and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Decrease in the numbers of dendritic cells and CD4+ T cells in cerebral perivascular spaces due to natalizumab

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

T-Cell Function and Migration — Two Sides of the Same Coin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta2 integrins are required for skin homing of primed T cells but not for priming naive T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2809%2970161-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(09)70161-5

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37568787&oldid=2092636600"